LR Health & Beauty reported its financial results for the first quarter of 2026. Sales in the quarter reached $71.6 million with a normalized EBITDA of $6.12 million. Sales fell 17.8% year-over-year. EBITDA declined from $8.7 million in the same quarter of 2025, which the company attributed to a decrease in sales as well as one-off effects related to its ongoing financial restructuring.
“During the first quarter of 2026, we reached important milestones in the realignment of our financing structure,” said Jörg Körfer, LR Health & Beauty SE CEO. “Accordingly, throughout the current year we will continue to focus on advancing our strategic initiatives in order to create the conditions for sustainably positive business development and growth. The successful outcome of our Business Days in April, attended by thousands of our distributors and featuring a promising product launch, clearly demonstrated that we can look to the future with confidence and achieve great success together with a strong partner community.”
The post LR Health & Beauty Reports Q1 2026 Financial Results first appeared on Direct Selling News.
